Massiel Pedreira

DOJ Recovers Up To $48 Million in False Claim Act Case Resulting From Whistleblower Report

In yet another large recovery for the DOJ, on December 6, 2012, DFB Pharmaceuticals, and its subsidiary, Healthpoint Ltd., agreed as part of a settlement to pay up to $48 million to resolve allegations that Healthpoint caused...more

1/24/2013 - DOJ False Claims Act Medicaid Medicare Pharmaceutical Qui Tam Whistleblowers